The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 27
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte SERGAZY M. ADEKENOV, and KANAT A. AITUGANOV
__________
Appeal No. 2002-0518
Application No. 08/934,471
__________
ON BRIEF
__________
Before WINTERS, ADAMS, and GRIMES, Administrative Patent Judges.
ADAMS, Administrative Patent Judge.
DECISION ON APPEAL
This is a decision on the appeal under 35 U.S.C. § 134 from the
examiner’s final rejection of claims 1, and 5-8 which are all the claims pending in
the application.
Claims 1 and 8 are illustrative of the subject matter on appeal and are
reproduced below:
1. A pharmaceutical composition in unit dosage form suitable for the
treatment of a human cancer, consisting essentially of about 40 mg to
about 480 mg of dimethylaminoarglabin or a pharmaceutically
acceptable salt thereof.
8. An article of manufacture comprising packaging material and a
pharmaceutical agent contained within said packaging material,
wherein said pharmaceutical agent is therapeutically effective for
suppressing tumor growth in a human, and wherein said packaging
material comprises a label that indicates that said pharmaceutical
agent can be used for suppressing tumor growth in a human, and
Page: 1 2 3 4 5 Next
Last modified: November 3, 2007